warning about reports of acute renal failure with Immune Globulin Intravenous (IVIG) products
January 1999
The FDA is now warning about reports of acute renal failure with Immune Globulin Intravenous (IVIG) products.
The risk appears to be highest with products that contain sucrose...Sandoglobulin, Panglobulin, and Gammar-P IV. These solutions can cause kidney damage due to their higher osmotic load.
Patients at increased risk are primarily those with pre-existing renal dysfunction...diabetes...and over 65.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote